ADVERTISEMENT
Brain cells with electrical firing. 3D rendering.
Microglia as Therapeutic Targets in Neurodegenerative Diseases
Pharmaceutical companies ramp up efforts to get the brain’s immune cells to help treat Alzheimer’s disease and other conditions, but not everyone agrees the approach will be effective.
Microglia as Therapeutic Targets in Neurodegenerative Diseases
Microglia as Therapeutic Targets in Neurodegenerative Diseases

Pharmaceutical companies ramp up efforts to get the brain’s immune cells to help treat Alzheimer’s disease and other conditions, but not everyone agrees the approach will be effective.

Pharmaceutical companies ramp up efforts to get the brain’s immune cells to help treat Alzheimer’s disease and other conditions, but not everyone agrees the approach will be effective.

small molecule drugs

?Sci Philo
Starting with Human Cell Systems 
The Scientist | Jul 24, 2023 | 1 min read
Xitiz Chamling shares how advances in human stem cell and gene editing technologies fuel his drive for better multiple sclerosis drug screening platforms.
Microscopy image of a fluorescent green oligodendrocyte surrounded by astrocytes stained red with blue nuclei.
Searching for a Direct Route to Multiple Sclerosis Treatment
Deanna MacNeil, PhD | Jul 17, 2023 | 3 min read
Researchers created a new high-throughput tool to hunt for therapies that remyelinate the nervous system.
 Learn about high-throughput flow cytometry for drug discovery
The New Age of Flow Cytometry
Bio-Rad Laboratories | Aug 3, 2022 | 1 min read
Technological advancements make flow cytometers an important tool for drug discovery research.
iStock
Characterizing Kinases for Therapeutics Targeting Innate Immunity
BellBrook Labs | May 17, 2022 | 1 min read
Universal kinase assays can quickly and effectively screen and triage novel hits.
Learn About the Benefits and Applications of High-Throughput Flow Cytometry
Fast and Furious: High-Throughput Flow Cytometry in Drug Discovery
Bio-Rad Laboratories | Feb 25, 2022 | 1 min read
Increasing automation, speed, and multiplexed analysis at all stages of drug discovery
Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
Rachael Moeller Gorman | Apr 1, 2021 | 10+ min read
Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.
Prioritizing Hits After Screening
The Scientist Staff | Mar 8, 2021 | 1 min read
Biochemical assays help researchers characterize and prioritize compounds following screens with enzyme targets.
Understanding Immune-Mediated Damage After Respiratory Infection
The Scientist Creative Services Team in collaboration with 10x Genomics | Feb 17, 2021 | 1 min read
Paul Thomas from St. Jude Children’s Research Hospital will discuss how he used single cell and spatial transcriptomics to discover the underlying mechanism of an inflammatory immune response in the lungs.
High Content Phenotypic Screening and Analysis Enhances Drug Discovery
The Scientist | Oct 7, 2020 | 1 min read
Molly Shoichet and Bridget Wagner discuss strategies for using phenotypic screening to identify novel agents against diseases such as cancer and diabetes.
The Scientist Speaks - Repurposing Living Systems to Fight a Pandemic
The Scientist | Sep 29, 2020 | 1 min read
Episode 9
Drug Helps Plants Resist Drought: Study
Abby Olena, PhD | Oct 24, 2019 | 3 min read
The small molecule is effective in tomato and wheat in laboratory trials, but its scalability and applicability to real-world agriculture remains to be seen.
Antibiotic Assistants
Ruth Williams | Mar 9, 2016 | 3 min read
Scientists discover compounds that restore antibiotic efficacy against drug-resistant superbugs.  
Broccoli Molecule May Ease Autism Symptoms
Molly Sharlach | Oct 14, 2014 | 2 min read
A small study found improvements in behavior and communication skills among young men treated with sulforaphane.
Some Assembly Required
Tracy Vence | Sep 3, 2013 | 1 min read
Researchers construct nanoscale DNA cages that could eventually be used to deliver drugs to target tissues.
Cancer Growth Curtailed
Ruth Williams | Apr 4, 2013 | 3 min read
Researchers develop two small molecules that slow the growth of human cancer cells.
Size Matters to Industry
Edyta Zielinska | Apr 11, 2012 | 1 min read
Large molecules are more likely to make it to market these days than small molecules, according to new reports.
ADVERTISEMENT